Castellano Ingles Portugues
Home  Home
Contact News

doping prevention
drug abuse
treatment centers
drug test
toxicology industry products
laboratories equipments
Antidoping laboratories in Americas
Antidoping laboratories in Africa
Antidoping laboratories in Asia
Antidoping laboratories in Europe
Antidoping laboratories in Oceania
World Anti-Doping Agency
ANADO  assist national anti-doping organizations
antidoping reserarch organizations
National antidoping Organizations  of America
Africa National Organization of Antidoping
National antidoping organizations of Asia
National antidoping Organizations  of  Europe
National antidoping Organizations  of  Oceania
links about anti doping
2014 FIFA World Cup Brazil - antidoping news
2010 FIFA World Cup South Africa  - Antidoping news
olympic games Rio 2016

Antidoping > drug abuse


Drug abuse:

has a huge range of definitions related to taking a psychoactive drug or performance enhancing drug for a non-therapeutic or non-medical effect. All of these definitions imply a negative judgment of the drug use in question (compare with the term responsible drug use for alternative views).



Some of the drugs most often associated with this term include alcohol, amphetamines, barbiturates, benzodiazepines, cocaine, methaqualone, and opium alkaloids. Use of these drugs may lead to criminal penalty in addition to possible physical, social, and psychological harm, both strongly depending on local jurisdiction. Other definitions of drug abuse fall into four main categories: public health definitions, mass communication and vernacular usage, medical definitions, and political and criminal justice definitions.






  The National Institute on Drug Abuse (NIDA)

is the Federal focal point for research on drug abuse and addiction. Established in 1974, NIDA became part of the National Institutes of Health, Department of Health and Human Services, in October 1992. NIDA's mission is to lead the Nation in bringing the power of science to bear on drug abuse and addiction. In this regard, NIDA addresses the most fundamental and essential questions about drug abuse - from detecting and responding to emerging drug abuse trends and understanding how drugs work in the brain and body to developing and testing new treatment and prevention approaches.

Contacting NIDA
Questions for our staff?
E-mail information@nida.nih.gov or call 301-443-1124
(240-221-4007 en espaņol)

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services.





  National Anti-drug Strategy - Canada

The Prevention Action Plan

The Prevention Action Plan focuses on preventing illicit drug use among young people. It will provide information to those most affected by drug use, including parents, young people, educators, law enforcement authorities, and communities.

The Prevention Action Plan will:
refocus existing community-based drug-use prevention strategies, programs and services for youth;
provide information directly to parents, educators and health professionals;
develop materials for school-based awareness and prevention strategies for elementary and secondary school students;
discourage illicit drug use through a new, national public awareness campaign; and provide financial help to communities for local projects to tackle the growing challenge of illicit drug use among young people.
The Government of Canada has committed $30 million in new funding over five years to support the Prevention Action Plan. This new funding will bolster existing prevention efforts.







 





   Information Books Articles